GlassScriptPhysician profile
Scott Yarmark
NPI 1265548648
$22,503.70
in general payments reported to CMS, 2019-2025
83 companies · $3,469 in 2025
The $3,469 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,770 · 2020: $2,669 · 2021: $3,031 · 2022: $3,089 · 2023: $3,426 · 2024: $3,049 · 2025: $3,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,924 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,923.76 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,521.31 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $2,063.66 | 2019-2025 | |
| Abbvie INC. | $1,795.41 | 2019-2025 | Vraylar, Qulipta |
| Lilly USA, LLC | $1,506.47 | 2019-2025 | Mounjaro, Jardiance, Kisunla |
| Amgen INC. | $1,433.41 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,427.53 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,155.36 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $820.92 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $774.37 | 2023-2025 | Gemtesa, Aptiom |
| Bayer Healthcare Pharmaceuticals INC. | $657.58 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $462.48 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $393.18 | 2019-2025 | |
| Allergan, INC. | $368.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $360.49 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $341.05 | 2019-2024 | Spiriva Respimat, Jardiance |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $318.50 | 2019-2025 | Rexulti, Nuedexta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $304.24 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $292.94 | 2019-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Avanir Pharmaceuticals, INC. | $278.05 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $266.44 | 2019-2023 | |
| Axsome Therapeutics, INC. | $233.29 | 2023-2025 | Auvelity, Symbravo, Sunosi |
| Teva Pharmaceuticals USA, INC. | $228.69 | 2020-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $207.73 | 2023-2025 | Rexulti |
| Amarin Pharma, INC. | $205.75 | 2019-2021 | |
| Shield Therapeutics INC | $193.94 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $185.99 | 2019-2022 | |
| Daiichi Sankyo INC. | $177.33 | 2019-2025 | Injectafer |
| Exact Sciences Corporation | $159.10 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $153.14 | 2021-2025 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $148.79 | 2020-2022 | |
| Upsher-Smith Laboratories LLC | $147.17 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $130.38 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $124.01 | 2025 | Voquezna |
| Supernus Pharmaceuticals, INC. | $121.73 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $116.27 | 2020-2022 | |
| Ucb, INC. | $116.04 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $107.29 | 2022-2024 | Ingrezza |
| Biohaven Pharmaceuticals, INC. | $106.64 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $104.07 | 2020-2023 | Nuplazid |
| Sanofi Pasteur INC. | $100.01 | 2019-2025 | |
| Urovant Sciences INC | $92.86 | 2021-2022 | |
| Intuity Medical INC | $91.98 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Biohaven Pharmaceutical Holding Company LTD. | $88.03 | 2022 | |
| Radius Health, INC. | $85.01 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $81.93 | 2021-2022 | |
| Boston Scientific Corporation | $76.53 | 2022-2025 | General - Dbs, Spectra Wavewriter |
| Verona Pharma, INC. | $75.41 | 2025 | Ohtuvayre |
| Ardelyx, INC. | $75.36 | 2024-2025 | Ibsrela |
| Seqirus USA INC | $67.74 | 2019-2024 | Flucelvax Quadrivalent, Flucelvax, Fluad |
| E.R. Squibb & Sons, L.L.C. | $66.48 | 2020-2023 | Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.79 | 2025 | Caplyta |
| Eisai INC. | $56.55 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.86 | 2024-2025 | Trintellix, Eohilia |
| Jazz Pharmaceuticals INC. | $53.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $53.40 | 2019 | |
| Scilex Pharmaceuticals INC. | $50.86 | 2019-2020 | |
| Biogen, INC. | $48.33 | 2021-2024 | Leqembi |
| Shire North American Group INC | $45.27 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.67 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Aimmune Therapeutics, INC. | $44.47 | 2024-2025 | Zenpep |
| Kowa Pharmaceuticals America, INC. | $44.17 | 2020-2025 | Zoryve |
| Acorda Therapeutics, INC | $42.52 | 2019 | |
| Inspire Medical Systems, INC. | $41.32 | 2025 | Inspire |
| Vbi Vaccine (Delaware) INC. | $41.15 | 2022-2023 | Prehevbrio |
| Bausch Health US, LLC | $39.27 | 2019-2020 | |
| Gilead Sciences, INC. | $27.62 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $27.51 | 2023 | Quviviq |
| Pacira Therapeutics, INC. | $26.79 | 2019 | |
| Linus Health, INC. | $26.31 | 2023 | |
| Vanda Pharmaceuticals INC. | $26.20 | 2025 | Fanapt |
| Assertio Therapeutics, INC. | $25.77 | 2019 | |
| Evoke Pharma, INC. | $24.42 | 2021 | |
| Alnylam Pharmaceuticals INC. | $22.23 | 2025 | Onpattro |
| Insmed, INC. | $19.33 | 2025 | Arikayce |
| Vertos Medical, INC. | $19.07 | 2024 | Mild Device Kit |
| Genentech USA, INC. | $18.36 | 2025 | Ocrevus Zunovo |
| Ironwood Pharmaceuticals, INC | $17.30 | 2019 | |
| Medicomp INC | $16.54 | 2025 | Telepatch Cardiac Monitor |
| Redhill Biopharma INC. | $15.72 | 2020 | |
| Biodelivery Sciences International, INC. | $15.54 | 2020 | |
| Alkermes, INC. | $15.43 | 2023 | Aristada, Lybalvi |
| Nabriva Therapeutics, Plc | $15.38 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.45 | 2019 |
Drugs and devices associated with these payments
Vraylar $823Gemtesa $645Nurtec Odt $576Trelegy Ellipta $560Kerendia $497Repatha $476Rexulti $419Eliquis $393Otezla $361Airsupra $342Verquvo $294Qulipta $292Mounjaro $291Breztri $279Farxiga $264Veozah $263Wegovy $240Arexvy $229Jardiance $217Rybelsus $215Ozempic $215Comirnaty $214Ubrelvy $197Accrufer $194Paxlovid $192Lokelma $183Auvelity $163Cologuard Collection Kit $159Freestyle Libre 3 $157Zavzpret $150Belsomra $147Prevnar 20 $136Aptiom $129Voquezna $124Abrysvo $116Austedo Xr $107Dexcom G6 Transmitter $92.62Pogo Automatic Blood Glucose Monitoring System $91.98Ingrezza $82.61Leqvio $81.70Ohtuvayre $75.41Ibsrela $75.36Entresto $74.50Xifaxan $72.87Injectafer $68.33Kisunla $62.00Aristada $61.72Caplyta $58.79Steglatro $58.10Zepbound $48.00Vyndamax $46.51Gel-One Cross-Linked Hyaluronate $44.67Zenpep $44.47Flublok Quadrivalent Northern Hemisphere $43.06Fluzone High-Dose $43.06Inspire $41.32Trintellix $38.42Symbravo $35.91Soliqua 100/33 $34.75Sunosi $34.68General - Dbs $32.26Flucelvax Quadrivalent $32.16Nuplazid $30.24Shingrix $29.75Quviviq $27.51Core Cognitive Evaluation $26.31Fanapt $26.20Leqembi $25.99Prehevbrio $24.85Flucelvax $22.89Fluad $22.89Onpattro $22.23Proclaim $21.71Linzess $21.48Creon $21.48Freestyle Libre 2 $20.77Spiriva Respimat $20.10Spectra Wavewriter $19.47Arikayce $19.33Nucala $19.25Mild Device Kit $19.07Ocrevus Zunovo $18.36Zoryve $17.67Nuedexta $17.60Fluzone Quadrivalent Northern Hemisphere $17.49Vyndaqel $17.48Telepatch Cardiac Monitor $16.54Eohilia $16.44Lybalvi $15.43Trulicity $12.97
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Yarmark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.